Korro Bio (KRRO)

• Market cap: $77.4M
• 1 day: -3.77%
• 5 days: 1.28%
• 1 month: 28.62%
• 3 months: -73.96%
• 6 months: -37.22%
• Year to date: -80.72%
• 1 year: -84.1%
• 5 years: -99.6%
• 10 years: -98.85%
• Sector: Healthcare
• Industry: Biotechnology

About: Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Employees: 87